6-hydroxymelatonin has been researched along with Metabolic Syndrome in 2 studies
6-hydroxymelatonin : A member of the class of tryptamines that is melatonin with a hydroxy group substituent at position 6.
Metabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The incidence of dysmetabolic factors in 100 elderly patients with hypertension stage II and the role of melatoninproducing function of epiphysis (pineal gland) in the development of these disorders were studied." | 9.16 | [Metabolic disorders in elderly patients with hypertension and their correction with melatonin]. ( Antoniuk-Shcheglova, IA; Bondarenko, EV; Shatilo, VB, 2012) |
| "The level of 6-oxymelatonin sulfate, the main metabolite of melatonin (MT), in morning urine samples from patients with metabolic syndrome (MS) suggests enhanced MT production at night." | 7.75 | [The role of melatonin in the development of metabolic syndrome]. ( Balliuzek, MF; Grinenko, TN; Kvetnaia, TV, 2009) |
| "The incidence of dysmetabolic factors in 100 elderly patients with hypertension stage II and the role of melatoninproducing function of epiphysis (pineal gland) in the development of these disorders were studied." | 5.16 | [Metabolic disorders in elderly patients with hypertension and their correction with melatonin]. ( Antoniuk-Shcheglova, IA; Bondarenko, EV; Shatilo, VB, 2012) |
| "The level of 6-oxymelatonin sulfate, the main metabolite of melatonin (MT), in morning urine samples from patients with metabolic syndrome (MS) suggests enhanced MT production at night." | 3.75 | [The role of melatonin in the development of metabolic syndrome]. ( Balliuzek, MF; Grinenko, TN; Kvetnaia, TV, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balliuzek, MF | 1 |
| Grinenko, TN | 1 |
| Kvetnaia, TV | 1 |
| Shatilo, VB | 1 |
| Bondarenko, EV | 1 |
| Antoniuk-Shcheglova, IA | 1 |
1 trial available for 6-hydroxymelatonin and Metabolic Syndrome
| Article | Year |
|---|---|
[Metabolic disorders in elderly patients with hypertension and their correction with melatonin].
Topics: Aged; Antihypertensive Agents; Blood Glucose; Body Mass Index; Carbohydrate Metabolism; Drug Therapy | 2012 |
1 other study available for 6-hydroxymelatonin and Metabolic Syndrome
| Article | Year |
|---|---|
[The role of melatonin in the development of metabolic syndrome].
Topics: Aged; Aged, 80 and over; Aging; Circadian Rhythm; Disease Progression; Female; Humans; Male; Melaton | 2009 |